Ca2+ buffering action of sarcoplasmic reticulum on Bay k 8644-induced Ca2+ influx in rat femoral arterial smooth muscle

European Journal of Pharmacology

Volumn 366, Issue 1, 1999, Pages 61-71

  Asano, Masahisa ^a   Nomura, Yukiko ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

'Superficial buffer barrier' hypothesis; Arterial contraction; Ca2+ channel, L type; Ca2+ influx; Ca2+ level, cellular; Ca2+ ATPase; Sarcoplasmic reticulum

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ADENOSINE TRIPHOSPHATASE (CALCIUM); BUFFER; CALCIUM CHANNEL; CYCLOPIAZONIC ACID; NIFEDIPINE; RYANODINE; THAPSIGARGIN; CAFFEINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; CENTRAL STIMULANT AGENT; ENZYME INHIBITOR; INDOLE DERIVATIVE; POTASSIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; FEMORAL ARTERY; HYPOTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; ANIMAL; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; METABOLISM; MOUSE; MUSCLE CONTRACTION; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; CAFFEINE; CALCIUM; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMORAL ARTERY; INDOLES; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; POTASSIUM; RATS; RATS, INBRED WKY; RYANODINE; SARCOPLASMIC RETICULUM; THAPSIGARGIN;

EID: 0032586840     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00858-9     Document Type: Article

References (25)

1. Arunlakshana, O., Schild, H.O., 1959. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14, 48-58.
2. Asano, M., Aoki, K., Matsuda, T., 1986. Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 239, 198-205.
3. Asano, M., Aoki, K., Suzuki, Y., Matsuda, T., 1987. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries. J. Pharmacol. Exp. Ther. 243, 646-656.
4. Asano, M., Masuzawa, K., Matsuda, T., 1988. Evidence for reduced β-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats. Br. J. Pharmacol. 94, 73-86.
5. + channels in resting state of carotid arteries from SHR. Am. J. Physiol. 265, H843-H851.
6. Asano, M., Kuwako, M., Nomura, Y., Ito, K.M., Ito, K., Uyama, Y., Imaizumi, Y., Watanabe, M., 1996a. Possible mechanism of the potent vasoconstrictor actions of ryanodine on femoral arteries from spontaneously hypertensive rats. Br. J. Pharmacol. 118, 1019-1027.
7. Asano, M., Kuwako, M., Nomura, Y., Suzuki, Y., Shibuya, M., Sugita, K., Ito, K., 1996b. Possible mechanism of the potent vasoconstrictor responses to ryanodine in dog cerebral arteries. Eur. J. Pharmacol. 311, 53-60.
8. Chen, Q., Cannell, M., Van Breemen, C., 1992. The superficial buffer barrier in vascular smooth muscle. Can. J. Physiol. Pharmacol. 70, 509-514.
9. 2+-pump inhibitor of rat aortic muscle. Acta Pharmacol. Sin. 12, 53-58.
10. Hockerman, G.H., Peterson, B.Z., Johnson, B.D., Catterall, W.A., 1997. Molecular determinants of drug binding and action on L-type calcium channels. Annu. Rev. Pharmacol. Toxicol. 37, 361-396.
11. 45Ca influx and net Ca uptake into rabbit aortic smooth muscle. Eur. J. Pharmacol. 116, 299-305.
12. Laporte, R., Laher, I., 1997. Sarcoplasmic reticulum-sarcolemma interactions and vascular smooth muscle tone. J. Vasc. Res. 34, 325-343.
13. McDonald, T.F., Pelzer, S., Trautwein, W., Pelzer, D.J., 1994. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 74, 365-507.
14. 2+ uptake into sarcoplasmic reticulum (SR)(Abstract). Jpn. J. Pharmacol. 76 (Suppl. 1), 209P.
15. 2+ uptake function of sarcoplasmic reticulum (SR) in the resting and contracting states of femoral, mesenteric and carotid arteries of the rat (Abstract). Jpn. J. Pharmacol. 64 (Suppl. 1), 241 P.
16. ++ influx in rat femoral arterial smooth muscle. J. Pharmacol. Exp. Ther. 279, 830-837.
17. Nomura, Y., Asano, M., Ito, K., Uyama, Y., Imaizumi, Y., Watanahe, M., 1997. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats. Br. J. Pharmacol. 120, 65-73.
18. 2+ channels. Nature 303, 535-537.
19. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 264, 17816-17823.
20. 2+-ATPase. Proc. Natl. Acad. Sci. U.S.A. 87, 2466-2470.
21. Triggle, D.J., 1990. Calcium, calcium channels, and calcium channel antagonists. Can. J. Physiol. Pharmacol. 68, 1474-1481.
22. 2+-ATPase inhibitor, on contractile responses in skinned ileal smooth muscle. Br. J. Pharmacol. 106, 208-214.
23. i smooth muscle. Annu. Rev. Physiol. 51, 315-329.
24. Van Breemen, C., Chen, Q., Laher, I., 1995. Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol. Sci. 16, 98-105.
25. Wanstall, J.C., O'Donnell, S.R., 1989. Age influences responses of rat isolated aorta and pulmonary artery to the calcium channel agonist, Bay K 8644, and to potassium and calcium. J. Cardiovasc. Pharmacol. 13, 709-714.